Bio T-Gel Approved to Treat Male Hypogonadism

BioSante has received approval from the FDA for Bio T-Gel, a once-daily transdermal testosterone gel for the treatment of male hypogonadism, or low testosterone levels. Typically, a man's testosterone level is considered low if it is below a level of approximately 300ng/dL.

Low testosterone affects 4 to 5 million men over the age of 39 and is associated with a multitude of symptoms including loss of libido and sexual function, decreased energy, increased body fat, osteoporosis, reduced muscle mass, and loss of body hair.

For more information, visit www.biosantepharma.com.